Učitavanje...
Antiplatelet and anticoagulation for patients with prosthetic heart valves
BACKGROUND: Patients with prosthetic heart valves are at increased risk for valve thrombosis and arterial thromboembolism. Oral anticoagulation alone, or the addition of antiplatelet drugs, has been used to minimise this risk. An important issue is the effectiveness and safety of the latter strategy...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2013
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094423/ https://ncbi.nlm.nih.gov/pubmed/23839768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003464.pub2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|